InvestorsObserver
×
News Home

Is Ginkgo Bioworks Holdings Inc (DNA) Stock a Good Value Monday?

Monday, December 05, 2022 10:47 AM | InvestorsObserver Analysts

Mentioned in this article

Is Ginkgo Bioworks Holdings Inc (DNA) Stock a Good Value Monday?

A rating of 46 puts Ginkgo Bioworks Holdings Inc (DNA) near the top of the Healthcare sector according to InvestorsObserver. Ginkgo Bioworks Holdings Inc's score of 46 means that it ranks higher than 46% of stocks in the sector. In addition, its overall score of 18 ranks it higher than 18% of all stocks.

Overall Score - 18
DNA has an Overall Score of 18. Find out what this means to you and get the rest of the rankings on DNA!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Ginkgo Bioworks Holdings Inc Stock Today?

Ginkgo Bioworks Holdings Inc (DNA) stock is trading at $1.86 as of 10:30 AM on Monday, Dec 5, a decline of -$0.13, or -6.78% from the previous closing price of $1.99. The stock has traded between $1.84 and $1.97 so far today. Volume today is light. So far 5,592,895 shares have traded compared to average volume of 25,373,785 shares. Click Here to get the full Stock Report for Ginkgo Bioworks Holdings Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App